These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24245936)

  • 1. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming.
    Jung DW; Kim WH; Williams DR
    ACS Chem Biol; 2014 Jan; 9(1):80-95. PubMed ID: 24245936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining small molecules for cell reprogramming through an interatomic analysis.
    Feltes BC; Bonatto D
    Mol Biosyst; 2013 Nov; 9(11):2741-63. PubMed ID: 24056910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levels.
    Alexanian AR; Liu QS; Zhang Z
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1633-8. PubMed ID: 23665234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: A chemical approach to control cell fate and function.
    Li W; Jiang K; Ding S
    Stem Cells; 2012 Jan; 30(1):61-8. PubMed ID: 22028211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.
    Li W; Ding S
    Trends Pharmacol Sci; 2010 Jan; 31(1):36-45. PubMed ID: 19896224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecules for stem cells.
    Kochegarov A
    Expert Opin Ther Pat; 2009 Mar; 19(3):275-81. PubMed ID: 19441903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the reprogramming of somatic cells.
    Ma T; Xie M; Laurent T; Ding S
    Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
    Cebrian-Serrano A; Stout T; Dinnyes A
    Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Revolution in Reprogramming: Small Molecules.
    Zhou J; Sun J
    Curr Mol Med; 2019; 19(2):77-90. PubMed ID: 30914022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical biology in stem cell research.
    Choi Y; Nam TG
    Arch Pharm Res; 2012 Feb; 35(2):281-97. PubMed ID: 22370782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell extracts: use in differentiation and reprogramming.
    Han J; Sidhu K
    Regen Med; 2011 Mar; 6(2):215-27. PubMed ID: 21391855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of epigenome-modifying small molecules in induced pluripotent stem cells.
    Lu J; Kong X; Luo C; Li KK
    Med Res Rev; 2013 Jul; 33(4):790-822. PubMed ID: 22581616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.